Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial

Detalles Bibliográficos
Autores principales: Zander, Thilo, Pabst, Thomas, Schär, Sämi, Aebi, Stefan, Mey, Ulrich, Novak, Urban, Lerch, Erika, Rhyner Agocs, Gaëlle, Goede, Jeroen, Maniecka, Zuzanna, Hayoz, Stefanie, Rüfer, Axel, Renner, Christoph, Driessen, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991905/
https://www.ncbi.nlm.nih.gov/pubmed/36635391
http://dx.doi.org/10.1038/s41375-023-01809-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991905/
https://www.ncbi.nlm.nih.gov/pubmed/36635391
http://dx.doi.org/10.1038/s41375-023-01809-z

Ejemplares similares